June 2026
Alkem Labs – Launched semaglutide in single-shot pre-filled syringes at ₹350 (generic for Ozempic/Wegovy) for diabetes & obesity on June 4, 2026.
Lupin + Natco – Secured US FDA approval for Eribulin Mesylate Injection (1 mg/2 mL) for metastatic breast cancer & liposarcoma; bioequivalent to Halaven Injection, approved on June 3, 2026.
Anthem Biosciences – Received SEBI nod for ₹3,395 crore IPO (entirely OFS by promoters); IPO listed at 26.85% premium at ₹723.10 on BSE/NSE. SEBI approval date: April 8, 2025.
Wockhardt – CDSCO approved ZAYNICH® (Zidebactam/Cefepime) for complicated UTIs & pyelonephritis; India’s breakthrough antibiotic against antimicrobial resistance on May 27, 2026.
Zydus Therapeutics – FDA granted priority review to NDA for saroglitazar to treat primary biliary cholangitis in May 2026.
CDSCO – Mandated strict compliance with revised Schedule M at Pharmac South Expo on June 5, 2026, and directed all stakeholders to establish pharmacovigilance systems.
International Updates
UK Regulatory Authority – Approved Rilzabrutinib for adults with immune thrombocytopenia (blood disorder treatment) in June 2026.
Novo Nordisk – Launched Wegovy weight-loss pill in UAE (second country after US) on June 3, 2026.
Haisco Pharmaceuticals – Cipepofol became the first China-originated innovative IV anesthetic approved by US FDA in June 2026.
Wockhardt – ZAYNICH received FDA approval for complicated urinary tract infections, making it India’s second drug approved in the US in 2026.od this year. Haisco’s Cipepofol became the first China-originated innovative intravenous anesthetic approved by US FDA. Novo Nordisk launched Wegovy weight-loss pill in the UAE on June 3, 2026, marking the second country offering the pill after the US. FDA granted priority review status to Zydus Therapeutics’ NDA for saroglitazar to treat primary biliary cholangitis.
Pharmaceutical pharmaceutical and related areas including pharma are generating substantial coverage, with recent headlines pointing to active developments around pharmaceuticals. The Latest Pharma News section brings together the most relevant updates for professionals and stakeholders tracking this segment.
This section aggregates reporting from Reuters, simplywall.st, Powder & Bulk Solids, and other trusted industry sources. It offers a consolidated view of breaking news, policy updates, and announcements relevant to pharmaceutical and related developments.
Readers seeking deeper context may consult World Health Organisation for regulatory information and CDSCO for sector analysis and data. For research literature, PharmaBiz provides access to peer-reviewed publications on relevant topics.
Showing 30 articles
-
CSL to start clinical trials for new immunoglobulin manufacturing process
CSL to start clinical trials for new immunoglobulin manufacturing process Reuters
-
Lexicon Pharmaceuticals (LXRX) Nears Key HCM Readout On An Undervalued Narrative
Lexicon Pharmaceuticals (LXRX) Nears Key HCM Readout On An Undervalued Narrative simplywall.st
-
J&J's Proposed $5.5B Settlement Aims to End Talc Litigation
J&J's Proposed $5.5B Settlement Aims to End Talc Litigation Powder & Bulk Solids
-
GSK raises margin outlook, plots $2.5 billion restructuring to fast-track new drugs
GSK raises margin outlook, plots $2.5 billion restructuring to fast-track new drugs Reuters
-
Keeping drugs free of contaminants – pharmaceutical makers filter medications through tiny pores to keep them sterile and safe
Keeping drugs free of contaminants – pharmaceutical makers filter medications through tiny pores to keep them sterile and safe Japan Today
-
Uniquity Bio Taps Jason Moore as New SVP of Regulatory & Quality
Uniquity Bio Taps Jason Moore as New SVP of Regulatory & Quality Contract Pharma
-
Ministry of Ayush Overhauls Drugs Rules, 1945: Perpetual Manufacturing Licences, Revised GMP Standards, New Inspector Qualifications and Stronger Quality Controls for ASU Drug Industry
Ministry of Ayush Overhauls Drugs Rules, 1945: Perpetual Manufacturing Licences, Revised GMP Standards, New Inspector Qualifications and Stronger Quality Controls for ASU Drug Industry drugscontrol.org
-
Glenmark Pharmaceuticals launches Sugammadex Injection in US market
Glenmark Pharmaceuticals launches Sugammadex Injection in US market scanx.trade
-
MRG Group announces strategic collaboration with Arica Pharmaceutical
MRG Group announces strategic collaboration with Arica Pharmaceutical BioSpectrum India
-
Chandigarh University Researchers Develop an Economical Device for Accurate Drug Absorption Studies; to Help in Reducing Cost of Medicines by 40%
Chandigarh University Researchers Develop an Economical Device for Accurate Drug Absorption Studies; to Help in Reducing Cost of Medicines by 40% Business Standard
-
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley The Guardian
-
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials PR Newswire
-
Jyong Biotech Expands Global Licensing Push for Botanical Therapy Targeting Enlarging BPH Market
Jyong Biotech Expands Global Licensing Push for Botanical Therapy Targeting Enlarging BPH Market BioPharma APAC
-
BDR Pharmaceuticals eyes controlling stake in Acme Formulation
BDR Pharmaceuticals eyes controlling stake in Acme Formulation The Economic Times
-
The reform booster shot that transformed India into pharmacy of the world
The reform booster shot that transformed India into pharmacy of the world Business Standard
-
AstraZeneca Pharma receives ₹79.97 lakh NPPA demand for overcharging
AstraZeneca Pharma receives ₹79.97 lakh NPPA demand for overcharging scanx.trade
-
Big Pharma gets a lesson in trusting the science
Big Pharma gets a lesson in trusting the science Breakingviews
-
Blackburn goes after dark-money group calling her ‘queen pharma mama’
Blackburn goes after dark-money group calling her ‘queen pharma mama’ Tennessee Lookout
-
Peli BioThermal, PAXAFE Partnership Signals AI-Powered Cold Chain Future
Peli BioThermal, PAXAFE Partnership Signals AI-Powered Cold Chain Future Pharmaceutical Commerce
-
Alembic Pharma gets U.S. FDA nod for generic chronic constipation drug
Alembic Pharma gets U.S. FDA nod for generic chronic constipation drug The Hindu
-
Why Spray Drying Is Gaining Attention as a Biologics Lifecycle Management Strategy
Why Spray Drying Is Gaining Attention as a Biologics Lifecycle Management Strategy Contract Pharma
-
Biotechnology and Pharmaceutical Services Outsourcing Market to Reach US$ 128.9 Billion by 2034
Biotechnology and Pharmaceutical Services Outsourcing Market to Reach US$ 128.9 Billion by 2034 Market.us Media
-
Celonic, Leukocare Partner to Support Joint Clients in Complex Biologics Development
Celonic, Leukocare Partner to Support Joint Clients in Complex Biologics Development Contract Pharma
-
GSK prepares for patent cliff with $2.5B cost-cutting plan
GSK prepares for patent cliff with $2.5B cost-cutting plan BioPharma Dive
-
CCF completes delivery of NHS aseptic pharmacy unit in Portsmouth
CCF completes delivery of NHS aseptic pharmacy unit in Portsmouth Cleanroom Technology
-
Steriline Launches AI Tools for Sterile Fill-Finish Lines
Steriline Launches AI Tools for Sterile Fill-Finish Lines Contract Pharma
-
Biotech Stocks To Watch And Pharma Industry News
Biotech Stocks To Watch And Pharma Industry News Investor's Business Daily
-
FDA Complete Response Letters: Audit Trails and System Validation
FDA Complete Response Letters: Audit Trails and System Validation BioProcess International
-
Single Use Support Speeds Design Cycle for Pharmaceutical Industry with Siemens Xcelerator
Single Use Support Speeds Design Cycle for Pharmaceutical Industry with Siemens Xcelerator Automation.com
-
Fedrigoni addresses evolving pharmaceutical label industry
Fedrigoni addresses evolving pharmaceutical label industry Label and Narrow Web
